Malaria Diagnostics Market Size to Reach USD 795 Million by 2032 | Growth Trends & Forecasts According to a newly published market research report by 24LifeSciences, global malaria diagnostics market is valued at USD 672 million in 2026 and is projected to reach USD 795 million by 2034, growing at a compound annual growth rate (CAGR) of 2.8% during the forecast period. Malaria diagnostics, which encompasses a suite of tests including Rapid Diagnostic Tests (RDTs), molecular diagnostics (PCR), and microscopy, are fundamental for the accurate and timely detection of Plasmodium parasites. These tools are critical for initiating appropriate treatment, preventing severe complications, reducing transmission, and supporting global malaria elimination efforts. Their established efficacy in both high-transmission and low-transmission settings continues to underpin their indispensable role in public health programs and clinical practice worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9428/malaria-diagnostics-market

What Is the Future of the MicroRNA Market? Key Growth Drivers & Insights According to a newly published market research report by 24LifeSciences, global microRNA market was valued at USD 746 million in 2026 and is projected to reach USD 2,409 million by 2034, growing at a compound annual growth rate (CAGR) of 18.7% during the forecast period. MicroRNAs (miRNAs) are small non-coding RNA molecules approximately 22 nucleotides long that play a fundamental role in RNA silencing and post-transcriptional regulation of gene expression. Their critical function in cellular processes, coupled with their stability in bodily fluids, positions them as powerful biomarkers for disease detection, prognosis, and monitoring, particularly in oncology, cardiology, and neurology. The growing integration of miRNAs into advanced molecular diagnostics and therapeutic development pipelines underscores their expanding commercial importance. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8916/microrna-market

Meningitis Diagnosis and Treatment Market Size to Reach USD 5.12 Billion by 2032 | Key Trends & Forecasts Global meningitis diagnosis and treatment market is undergoing a pivotal transformation driven by heightened infectious disease vigilance, rapid adoption of molecular diagnostics, and expanding access to emergency clinical care. Valued at USD 3.02 billion in 2024, the market is projected to rise to USD 3.26 billion in 2025 and further reach USD 5.12 billion by 2032, growing at a CAGR of 6.8%. This reflects the global push toward faster pathogen detection, improved treatment regimens, and stronger public health infrastructure. Access the complete dataset, competitive insights, and expert forecasts at 24LifeSciences. https://www.24lifesciences.com/meningitis-diagnosis-and-treatment-market-9528